Standout Papers

<i>MET</i> Exon 14 Mutations in Non–Small-Cel... 2005 2026 2012 2019 1.3k
  1. MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression (2016)
    Mark M. Awad, Geoffrey R. Oxnard et al. Journal of Clinical Oncology
  2. Non-small-cell lung cancers: a heterogeneous set of diseases (2014)
    Chen Zhao, Christine M. Fillmore et al. Nature reviews. Cancer
  3. Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma (2017)
    Suzanne George, Diana Miao et al. Immunity
  4. Fuel feeds function: energy metabolism and the T-cell response (2005)
    Casey Fox, Peter S. Hammerman et al. Nature reviews. Immunology

Immediate Impact

13 by Nobel laureates 13 from Science/Nature 147 standout
Sub-graph 1 of 17

Citing Papers

Lung cancer
2021 Standout
Toward personalized treatment approaches for non-small-cell lung cancer
2021 Standout
9 intermediate papers

Works of Peter S. Hammerman being referenced

Genomic correlates of response to immune checkpoint blockade in microsatellite stable solid tumors.
2018
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
2017 Standout
and 5 more

Author Peers

Author Last Decade Papers Cites
Peter S. Hammerman 4205 2943 2017 2091 84 7.9k
Garret M. Hampton 5450 2539 1237 1895 93 8.9k
Ronit Simantov 5436 3293 4224 2630 87 11.0k
Carmen Behrens 5159 3859 2874 2590 167 9.3k
De‐Chen Lin 4138 2054 2145 2623 91 6.5k
Hartmut Koeppen 4842 4897 1501 1692 115 9.0k
Bijoyesh Mookerjee 4022 3611 2194 2296 84 7.3k
Kerstin Schmidt 3125 1886 1175 3487 53 7.0k
Pascal Finetti 4592 4850 1300 3435 175 9.6k
Yidong Chen 4158 1537 1351 1696 80 7.0k
Hal W. Hirte 3170 3594 1255 964 154 7.9k

All Works

Loading papers...

Rankless by CCL
2026